Literature DB >> 15473148

Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.

E Manaresi1, G Gallinella, A M Morselli Labate, P Zucchelli, D Zaccarelli, S Ambretti, S Delbarba, M Zerbini, M Musiani.   

Abstract

Serum samples from 446 Italian blood donors between 18 and 65 years of age were analysed for the presence of IgG against parvovirus B19 capsid proteins VP1 and VP2 including conformational and linear epitopes. The overall prevalence of IgG against parvovirus B19 capsid proteins VP1 and VP2 against at least one antigen type was 79.1 %. No significant difference was found between men and women. In the 18-27 years age group, 77.0 % of the population had experienced infection with the virus, reaching 88.5 % in the 48-57 years age group. The overall prevalence of IgG was 78.0 % against conformational VP1 + VP2 antigens, 74.9 % against conformational VP2, 70.9 % against linear VP1 and 23.3 % against linear VP2 in the analysis of the IgG response against different conformational and linear epitopes of VP1 and VP2. Although IgG against conformational VP1+VP2, conformational VP2 and linear VP1 was present in more than 60 % of subjects in all age groups, IgG against VP2 linear antigens was present in only 32% of subjects in the 18-27 years age group and then decreased to 20.5 % in the 28-37 years age group. A different trend was noted when IgG positivity against linear and conformational epitopes was analysed separately in men and women. A significant increase was found in seroprevalence of IgG against VP2 conformational antigens with increasing age in males and a significant decrease in seroprevalence of IgG against VP2 linear antigens in women with increasing age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473148      PMCID: PMC2870172          DOI: 10.1017/s0950268804002389

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2009-09

3.  Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.

Authors:  Armen Parsyan; Shane Kerr; Shirley Owusu-Ofori; Gordon Elliott; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

5.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

6.  Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.

Authors:  Erica Ollmann Saphire; Marinieve Montero; Alfredo Menendez; Nienke E van Houten; Melita B Irving; Ralph Pantophlet; Michael B Zwick; Paul W H I Parren; Dennis R Burton; Jamie K Scott; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-01-27       Impact factor: 5.469

7.  Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors.

Authors:  C Reinheimer; R Allwinn; H W Doerr; M Wittek
Journal:  Infection       Date:  2010-06-17       Impact factor: 7.455

Review 8.  Parvovirus B19: What Is the Relevance in Transfusion Medicine?

Authors:  David Juhl; Holger Hennig
Journal:  Front Med (Lausanne)       Date:  2018-02-01

9.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

10.  Overall prevalence of human parvovirus B19 among blood donors in mainland China: A PRISMA-compliant meta-analysis.

Authors:  Xin Li; Zheng Lin; Jiayan Liu; Yuanyuan Tang; Xiaohong Yuan; Nainong Li; Zhenxing Lin; Yuanzhong Chen; Ailin Liu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.